Individuals whose research has significant and enduring impact in their field of cancer research are elected as American Association for Cancer Research Fellows through a rigorous peer-review process.
The newly elected 2017 Class of Fellows includes three EACR members. They will join the AACR Academy to provide guidance and insight to the policy making of the AACR.
For designing chimeric antigen receptor T-cell immunotherapy for the treatment of refractory and relapsed chronic lymphocytic leukaemia.
Carl June joined the EACR in 2016 and this October he will be giving a Keynote Lecture at the EACR conference Defence is the Best Attack: Immuno-Oncology Breakthroughs. He is currently the director of translational research at the Abramson Cancer Center at the University of Pennsylvania, USA.
For advancing the understanding of DNA damage repair through his discovery of the process of base excision repair and for isolating and characterizing several key components of the DNA repair machinery.
Swedish-born scientist Tomas Lindahl has been an EACR member for over 20 years. Emeritus Group Leader at the Francis Crick Institute in London, UK, Tomas was jointly awarded the Nobel Prize for Chemistry in 2015 along with many other prestigious awards.
For describing various p53 regulatory mechanisms involved in carcinogenesis, including MDM2 inhibition of p53 function and the role of p53 upregulated modulator of apoptosis (PUMA) in p53-mediated cell death.
Karen Vousden, EACR member since 2013, is a Professor at the Francis Crick Institute in London, UK, and was appointed last year Chief scientist for Cancer Research UK.
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.